Literature DB >> 10986440

Benefits and risks of fetal red-cell transfusion after 32 weeks gestation.

F J Klumper1, I L van Kamp, F P Vandenbussche, R H Meerman, D Oepkes, S A Scherjon, P H Eilers, H H Kanhai.   

Abstract

OBJECTIVE: To compare the outcome after intrauterine transfusion (IUT) between fetuses treated before and those treated after 32 weeks gestation.
SETTING: National referral center for intrauterine treatment of red-cell alloimmunization in The Netherlands. STUDY
DESIGN: Retrospective evaluation of an 11 year period, during which 209 fetuses were treated for alloimmune hemolytic disease with 609 red-cell IUTs. We compared fetal and neonatal outcome in three groups: fetuses only treated before 32 weeks gestation (group A, n=46), those treated both before and after 32 weeks (group B, n=117), and those where IUT was started at or after 32 weeks (group C, n=46).
RESULTS: Survival rate was 48% in group A, 100% in group B, and 91% in group C. Moreover, fetuses in group A were hydropic significantly more often. Short-term perinatal loss rate after IUT was 3.4% in the 409 procedures performed before 32 weeks and 1.0% in the 200 procedures performed after 32 weeks gestation.
CONCLUSION: Perinatal losses were much more common in fetuses only treated before 32 weeks gestation. Two procedure-related perinatal losses in 200 IUT after 32 weeks remain a matter of concern because of the good prospects of alternative extrauterine treatment.

Entities:  

Mesh:

Year:  2000        PMID: 10986440     DOI: 10.1016/s0301-2115(00)00430-9

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  Management of pregnancies with RhD alloimmunisation.

Authors:  Sailesh Kumar; Fiona Regan
Journal:  BMJ       Date:  2005-05-28

2.  Neonatal outcome after fetal anemia managed by intrauterine transfusion.

Authors:  C Garabedian; T Rakza; D Thomas; B Wibaut; P Vaast; D Subtil; V Houfflin-Debarge
Journal:  Eur J Pediatr       Date:  2015-06-02       Impact factor: 3.183

3.  Obstetric management in Rh alloimmunizated pregnancy.

Authors:  Alessandra Cacciatore; Stefania Rapiti; Sabina Carrara; Alessandro Cavaliere; Santina Ermito; Angela Dinatale; Laura Imbruglia; Stefania Recupero; Tindara La Galia; Elisa Maria Pappalardo; Manuela Chiara Accardi
Journal:  J Prenat Med       Date:  2009-04

4.  Prognosis and Management in Subsequent Rh Alloimmunized Pregnancies.

Authors:  Andreea Dumitru; Nicolae Gica; Radu Botezatu; Gheorghe Peltecu
Journal:  Maedica (Bucur)       Date:  2021-12

5.  Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.

Authors:  Arwa Z Al-Riyami; Mouza Al-Salmani; Sabria N Al-Hashami; Sabah Al-Mahrooqi; Ali Al-Marhoobi; Sumaiya Al-Hinai; Saif Al-Hosni; Sathiya M Panchatcharam; Zainab A Al-Arimi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-04-04

6.  Educational Case: Alloimmunization of pregnancy.

Authors:  Ingmar N Bastian; William N Rose
Journal:  Acad Pathol       Date:  2022-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.